Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients

Menchini, Laura; Rémy‐Jardin, Martine; Faivre, J; Copin, Marie‐Christine; Ramon, P; Matran, Régis; Deken, Valérie; Duhamel, Alain; Rémy, Jacques

doi:10.1183/09031936.00018709

Cited by 33 publications

(34 citation statements)

References 33 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If bronchoscopy reveals the lesion, artery embolization should be the next step followed by surgery, if required. If bronchoscopy does not reveal any abnormality, a cryptogenic massive hemoptysis is diagnosed and embolization may be indicated, particularly in smokers (17).…”

Section: Massive Hemoptysismentioning

confidence: 99%

“…According to different authors, etiology of hemoptysis cannot be determined in 3% to 42% of cases and it is defined as cryptogenic (7,16,17). Nevertheless, it has been demonstrated that a proportion of patients presenting with hemoptysis without any morbidity are smokers, and bleeding in smokers should be defined as smoke-related (occurring as a result of tobacco-induced bronchial wall inflammation), rather than cryptogenic (17).…”

mentioning

confidence: 99%

“…Nevertheless, it has been demonstrated that a proportion of patients presenting with hemoptysis without any morbidity are smokers, and bleeding in smokers should be defined as smoke-related (occurring as a result of tobacco-induced bronchial wall inflammation), rather than cryptogenic (17). Moreover, with a more systematic use of chest computed tomography (CT), particularly multidetector CT (MDCT), a decrease in the prevalence of hemoptysis without known cause might be expected (17).…”

mentioning

confidence: 99%

See 2 more Smart Citations

Diagnosis and management of hemoptysis

Larici

Franchi²,

Occhipinti³

et al. 2014

Diagn Interv Radiol

142

View full text Add to dashboard Cite

Hemoptysis is the expectoration of blood that originates from the lower respiratory tract. It is usually a self-limiting event but in fewer than 5% of cases it may be massive, representing a life-threatening condition that warrants urgent investigations and treatment. This article aims to provide a comprehensive literature review on hemoptysis, analyzing its causes and pathophysiologic mechanisms, and providing details about anatomy and imaging of systemic bronchial and nonbronchial arteries responsible for hemoptysis. Strengths and limits of chest radiography, bronchoscopy, multidetector computed tomography (MDCT), MDCT angiography and digital subtraction angiography to assess the cause and lead the treatment of hemoptysis were reported, with particular emphasis on MDCT angiography. Treatment options for recurrent or massive hemoptysis were summarized, highlighting the predominant role of bronchial artery embolization. Finally, a guide was proposed for managing massive and nonmassive hemoptysis, according to the most recent medical literature.

show abstract

Section: Massive Hemoptysismentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Diagnosis and management of hemoptysis

Larici

Franchi²,

Occhipinti³

et al. 2014

Diagn Interv Radiol

142

View full text Add to dashboard Cite

show abstract

“…Bronşiektazi, kronik bronşit, tüberküloz, mikotik akciğer enfeksiyonları, akciğer apsesi, kronik inflamatuar hastalıklar ile birlikte neoplastik hastalıklar anjiogenik büyüme faktörlerin salgılanmasını sağlayarak pulmoner damar neovasküla-rizasyona neden olurlar. Bu yeni kollateral damarlar frajildir ve hava yolu içine kanama eğilimindedirler (19)(20)(21).…”

Section: Akci̇ğeri̇n Arteryel Anatomi̇si̇ Ve Hemopti̇zi̇ni̇n Patofi̇zyoloji̇k unclassified

Hemoptysıs and General Approach

Metin¹,

Yıldırım²,

İntepe³

et al. 2015

Toraks Cer Bult

View full text Add to dashboard Cite

Hemoptysis is the expectoration of blood or blood-stained sputum originating from the lung or bronchi. Hemoptysis is a commonly encountered symptom that should be searched for promptly in clinical practice. Most of the patients with hemoptysis have minor or limited-type hemoptysis, but less than 5% of patients present with massive hemoptysis, which is severe enough to threaten life and necessitates urgent intervention. Although a blood volume of more than 100 ml expectorated within 24 hours is generally considered massive hemoptysis, there is no universally accepted volume that defines massive hemoptysis. Instead of considering the amount of blood expectoration at once as the only criterion for massive hemoptysis, it is more suitable and functional to define massive hemoptysis as a large amount of blood expectoration that puts the life of patients in danger.

show abstract

“…In our study we considered following classification system; <100 cc/day of hemoptysis as mild, 100-150 cc/day as moderate, 150-200 cc/day as severe, and >500 cc/day of expectorated blood in 24 hours or rate of blood loss >150ml/hr or 200ml blood loss/day for more than 3 days as massive hemoptysis. [3][4][5][6] The source of bleeding is usually from erosion of systemic rather than pulmonary arteries. Notable exceptions are arterio-venous malformations and pulmonary artery aneurysms.…”

Section: Introductionmentioning

confidence: 99%